This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Modernatx, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Nicholas J Amato in mRNA Quantification Methods
Introduction
Nicholas J Amato is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of mRNA quantification. His innovative methods have the potential to enhance the accuracy and efficiency of RNA measurement in various applications.
Latest Patents
Nicholas J Amato holds a patent for mRNA quantification methods. This patent provides methods for determining the concentration of RNA, specifically mRNA, in a solution. The process involves digesting the target RNA polymer by adding a base to a solution of RNA, which may include at least one chemically modified nucleotide. The mixture is then incubated to digest the RNA into a plurality of nucleotides. The absorbance of the digested RNA mixture is measured at 260 nm, and this measurement is used alongside a value of a relative percent of each nucleotide in the digestion mixture, as well as a mass-corrected coefficient of each nucleotide, to determine the concentration of the RNA. Additionally, the patent discusses using computer-implemented techniques to measure RNA concentration in a solution.
Career Highlights
Nicholas J Amato is currently associated with Modernatx, Inc., where he continues to work on innovative solutions in biotechnology. His expertise in RNA quantification methods has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Nicholas has collaborated with talented individuals such as Penggao Duan and Huijuan Li. These collaborations have contributed to the advancement of research and development in RNA technologies.
Conclusion
Nicholas J Amato's contributions to mRNA quantification methods exemplify the importance of innovation in biotechnology. His work not only enhances scientific understanding but also paves the way for future advancements in RNA research.